高级检索
当前位置: 首页 > 详情页

Comparative analysis of effectiveness of asthma control test-guided treatment versus usual care in patients with asthma from China

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China [2]Cent Hosp Minghang Dist, Shanghai, Peoples R China [3]Cent Hosp Jiading Dist, Shanghai, Peoples R China [4]Cent Hosp Qingpu Dist, Shanghai, Peoples R China [5]Peoples Hosp Pudong New Area, Shanghai, Peoples R China [6]Peoples Hosp Putuo Dist, Shanghai, Peoples R China [7]Gongli Hosp, Shanghai, Peoples R China [8]Fifth Peoples Hosp Shanghai, Shanghai, Peoples R China [9]Cent Hosp Yangpu Dist, Shanghai, Peoples R China [10]455 Hosp, Shanghai, Peoples R China [11]Shibei Hosp, GongheXin Rd, Shanghai, Peoples R China [12]Tongren Hosp, Shanghai, Peoples R China [13]GlaxoSmithKline, Shanghai, Peoples R China [14]GlaxoSmithKline, Shanghai R&D, Shanghai, Peoples R China
出处:
ISSN:

关键词: Adverse event Asthma quality of life questionnaire Exacerbations Forced expiratory volume in 1 s Inhaled corticosteroids Long-acting beta 2 agonist Prospective Randomized Serious adverse event

摘要:
Objective: The present study compared the effectiveness of asthma control test (ACT)-guided treatment vs. usual care (UC) in patients with asthma from China. Methods: This prospective, phase IV, multicenter, cluster-randomized, open-label 24-week study was conducted in China; patients were randomized to either ACT-guided treatment or UC group. The patients recorded peak expiratory flow, symptoms, and medication in a diary card every day and completed ACT at every clinic visit. For the UC group, patients completed ACT after the physician's treatment decision. Results: In total, 83.6% patients (n = 443/530; ACT: n = 209, UC: n = 234) completed the study. A significantly higher proportion of patients (adjusted OR [95% CI]: 7.87 (1.29, 48.11; p = 0.027) responded to the treatment and had ACT total score >= 20 or demonstrated an improvement of >3 points in ACT total score in >= 1 post-baseline assessment in the ACT-guided treatment vs. UC group. A higher proportion of patients had an ACT total score >= 20 and an improvement of >3 points in ACT total score at Week 24 in the ACT-guided treatment vs. the UC group (adjusted OR (95% CI):2.28 (1.07, 4.85; p = 0.036). A significant difference (p = 0.005) in change from baseline in ACT total score was observed in ACT-guided treatment vs. UC group at Week 24. The mean annual exacerbation rate was similar in both the groups. Conclusions: ACT-guided treatment was more effective in achieving ACT total score >= 20 or showing an improvement of >3 points in the ACT total score and well tolerated compared with UC treatment in the 24-week treatment period.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统 3 区 呼吸系统
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统 3 区 呼吸系统
JCR分区:
出版当年[2019]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Q2 RESPIRATORY SYSTEM
最新[2023]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Q2 RESPIRATORY SYSTEM

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China [*1]Zhongshan hospital, Fudan University, Shanghai, 200032, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)